MetalloBio
metallobio are developing two novel antimicrobial leads to treat pathogenic, multi-drug resistant infections caused by gram-negative bacteria.
Last updated on
About MetalloBio
Founded
2021Employees
1-10Funding / Mkt. Cap
$573KCategory
Location
City
South YorkshireState
RotherhamCountry
United KingdomMetalloBio
Find your buyer within MetalloBio
Tech Stack (20)
